Pathophysiological Insight into Fatty Acid-Binding Protein-4: Multifaced Roles in Reproduction, Pregnancy, and Offspring Health

Int J Mol Sci. 2023 Aug 10;24(16):12655. doi: 10.3390/ijms241612655.

Abstract

Fatty acid-binding protein-4 (FABP4), commonly known as adipocyte-fatty acid-binding protein (A-FABP), is a pleiotropic adipokine that broadly affects immunity and metabolism. It has been increasingly recognized that FABP4 dysfunction is associated with various metabolic syndromes, including obesity, diabetes, cardiovascular diseases, and metabolic inflammation. However, its explicit roles within the context of women's reproduction and pregnancy remain to be investigated. In this review, we collate recent studies probing the influence of FABP4 on female reproduction, pregnancy, and even fetal health. Elevated circulating FABP4 levels have been found to correlate with impaired reproductive function in women, such as polycystic ovary syndrome and endometriosis. Throughout pregnancy, FABP4 affects maternal-fetal interface homeostasis by affecting both glycolipid metabolism and immune tolerance, leading to adverse pregnancy outcomes, including miscarriage, gestational obesity, gestational diabetes, and preeclampsia. Moreover, maternal FABP4 levels exhibit a substantial linkage with the metabolic health of offspring. Herein, we discuss the emerging significance and potential application of FABP4 in reproduction and pregnancy health and delve into its underlying mechanism at molecular levels.

Keywords: FABP4; fetal–maternal health; immune regulation; metabolism; offspring; placenta; pregnancy complications; pregnancy outcomes; women reproduction.

Publication types

  • Review

MeSH terms

  • Abortion, Spontaneous*
  • Adipokines
  • Cardiovascular Diseases*
  • Child
  • Child Health
  • Fatty Acid-Binding Proteins
  • Female
  • Humans
  • Pregnancy

Substances

  • Adipokines
  • Fatty Acid-Binding Proteins

Grants and funding

This work did not receive any specific grant from public, commercial, or non-profit funding agencies.